As part of our ongoing seminar series, the Centre of Research Excellence in Severe Asthma is pleased to host Dr Robert Niven (University of Manchester, University Hospital of South Manchester), for a webinar on Clinical Trials Endpoints for Severe Asthma. This presentation will be a public lecture and also available live and online.

The seminar will take place on Wednesday, 08 March 2017 @ 2 PM at the Hunter Medical Research Institute, Newcastle (Caves Theatre).

 To register for the online webinar, go to: https://attendee.gotowebinar.com/register/613736775790452482

Dr. Niven runs a supra-regional service for severe asthma. He has assessed over 2,000 severe asthma patients, with around 50% of these referrals being for patients on maintenance oral steroids. He is a core member of the UK National Severe Asthma Network, with nearly 1,000 patients entered onto a national database from multiple centres, with Manchester a core contributor.

He has published over 100 peer-reviewed papers and 5 book chapters. Areas of interest have included occupational lung disease, environmental epidemiology and clinical practice in severe asthma. His research has assessed hypertonic saline for bronchiectasis therapy, awareness and diagnosis of dysfunctional breathing patterns, the role of antifungal therapy in severe asthma with fungal sensitisation and trials of bronchial thermoplasty and new biologics.

For attendees that are able to make it in person, refreshments will be served before the seminar, starting from 1:30 PM.

Dr. Niven’s presentation will be available as an online live webinar, and after the event will be available in the past webinars section of this website.

If you are interested in hearing more about our events and research, subscribe to our email list on our homepage or follow us on Twitter (@SevereAsthmaCRE).

If you would like to attend in person, please RSVP to severeasthma@newcastle.edu.au